BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1354721)

  • 1. The effect of 5-lipoxygenase inhibition on blood-brain barrier permeability in experimental brain tumors.
    Baba T; Chio CC; Black KL
    J Neurosurg; 1992 Sep; 77(3):403-6. PubMed ID: 1354721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective blood-tumor barrier disruption by leukotrienes.
    Chio CC; Baba T; Black KL
    J Neurosurg; 1992 Sep; 77(3):407-10. PubMed ID: 1506887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary permeability factor secreted by malignant brain tumor. Role in peritumoral brain edema and possible mechanism for anti-edema effect of glucocorticoids.
    Ohnishi T; Sher PB; Posner JB; Shapiro WR
    J Neurosurg; 1990 Feb; 72(2):245-51. PubMed ID: 2104924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against leukotrienes as mediators of brain edema.
    Unterberg A; Schmidt W; Wahl M; Ellis EF; Marmarou A; Baethmann A
    J Neurosurg; 1991 May; 74(5):773-80. PubMed ID: 2013778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of the blood-brain barrier in experimental metastatic brain tumors.
    Hasegawa H; Ushio Y; Hayakawa T; Yamada K; Mogami H
    J Neurosurg; 1983 Aug; 59(2):304-10. PubMed ID: 6864299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that endogenous generation of leukotrienes does not regulate proliferation of malignant hemopoietic cell lines.
    Ayyub Khan M; Tateson JE; Hoffbrand AV; Wickremasinghe RG
    Leuk Res; 1993 Mar; 17(3):241-5. PubMed ID: 8450672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of postischemic brain hypoperfusion and reperfusion injury by the cyclooxygenase-lipoxygenase inhibitor BW755C.
    Chen J; Weinstein PR; Graham SH
    J Neurosurg; 1995 Jul; 83(1):99-104. PubMed ID: 7782858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukotrienes increase blood-brain barrier permeability following intraparenchymal injections in rats.
    Black KL; Hoff JT
    Ann Neurol; 1985 Sep; 18(3):349-51. PubMed ID: 2996417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible non-involvement of lipoxygenase pathway in the cerebral blood flow decrease due to indomethacin.
    el Bouchi N; Fradin A; Capdeville C; Allix M; Plotkine M; Russo-Marie F; Boulu RG
    Eur J Pharmacol; 1985 Aug; 114(3):273-82. PubMed ID: 3933988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of leukotrienes as mediator compounds in brain edema.
    Unterberg A; Schmidt W; Wahl M; Baethmann A
    Adv Neurol; 1990; 52():211-4. PubMed ID: 2118715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of soybean lipoxygenase by lipoxygenase inhibitors in the presence of 15-hydroperoxyeicosatetraenoic acid.
    Reynolds CH
    Biochem Pharmacol; 1988 Dec; 37(23):4531-7. PubMed ID: 3144281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the arachidonate lipoxygenase inhibitor BW755C on traumatic and peritumoural brain oedema.
    Ikeda Y; Long DM
    Acta Neurochir Suppl (Wien); 1990; 51():68-70. PubMed ID: 2128585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracarotid infusion of leukotriene C4 selectively increases blood-brain barrier permeability after focal ischemia in rats.
    Baba T; Black KL; Ikezaki K; Chen KN; Becker DP
    J Cereb Blood Flow Metab; 1991 Jul; 11(4):638-43. PubMed ID: 1675639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow.
    Hiesiger EM; Voorhies RM; Basler GA; Lipschutz LE; Posner JB; Shapiro WR
    Ann Neurol; 1986 Jan; 19(1):50-9. PubMed ID: 3080944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of BW 755C and nordihydroguaiaretic acid in the rat isolated perfused mesenteric vasculature.
    Stanton BJ; Coupar IM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):199-207. PubMed ID: 3103138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition.
    Simmons RD; Hugh AR; Willenborg DO; Cowden WB
    Acta Neurol Scand; 1992 Mar; 85(3):197-9. PubMed ID: 1575003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic barrier protects brain capillaries from leukotriene C4.
    Black KL; Baba T; Pardridge WM
    J Neurosurg; 1994 Nov; 81(5):745-51. PubMed ID: 7931622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of brain tissue leukotriene in brain oedema following cerebral ischaemia: effect of a 5-lipoxygenase inhibitor, AA-861.
    Mabe H; Nagai H; Suzuka T
    Neurol Res; 1990 Sep; 12(3):165-8. PubMed ID: 1979846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of the lipoxygenase pathway specifically block orthopoxvirus replication.
    Palumbo GJ; Buller RM
    Virology; 1991 Jan; 180(1):457-63. PubMed ID: 1898625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipoxygenase inhibitors enhance the proliferation of human B cells.
    Behrens TW; Lum LG; Lianos EA; Goodwin JS
    J Immunol; 1989 Oct; 143(7):2285-94. PubMed ID: 2506281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.